Antibodies News and Research

RSS
Evaluating the trustworthiness and characteristics of COVID-19-related trial preprints

Evaluating the trustworthiness and characteristics of COVID-19-related trial preprints

7 Apr 2022
Study suggests blunted serological responses not responsible for COVID-19 mortality

Study suggests blunted serological responses not responsible for COVID-19 mortality

7 Apr 2022
Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

7 Apr 2022
Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

7 Apr 2022
Study finds vaccines effectively reduce deaths from COVID-19 but not the prevalence of infections

Study finds vaccines effectively reduce deaths from COVID-19 but not the prevalence of infections

7 Apr 2022
COVID boosters protect you better than monoclonal antibodies, or natural infection

COVID boosters protect you better than monoclonal antibodies, or natural infection

6 Apr 2022
Study investigates the breast milk microbiome in HIV-positive mothers

Study investigates the breast milk microbiome in HIV-positive mothers

6 Apr 2022
Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

6 Apr 2022
Insights into the pathophysiology of NeuroCOVID

Insights into the pathophysiology of NeuroCOVID

6 Apr 2022
Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

6 Apr 2022
Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

6 Apr 2022
Study evaluates the presence of the SARS-CoV-2 spike protein in urine samples collected during the COVID-19 pandemic

Study evaluates the presence of the SARS-CoV-2 spike protein in urine samples collected during the COVID-19 pandemic

6 Apr 2022
Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

6 Apr 2022
Study highlights immune escape mutations in viral N-terminal domain supersite of SARS-CoV-2 spike variants

Study highlights immune escape mutations in viral N-terminal domain supersite of SARS-CoV-2 spike variants

6 Apr 2022
Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

6 Apr 2022
Developing and manufacturing custom recombinant antibodies for R&D

Developing and manufacturing custom recombinant antibodies for R&D

From Sino Biological Inc. 6 Apr 2022
How comorbidities impact antibody response to COVID vaccination

How comorbidities impact antibody response to COVID vaccination

6 Apr 2022
Study says duplilumab reduces mortality from COVID-19

Study says duplilumab reduces mortality from COVID-19

5 Apr 2022
Swedish HCW study shows COVID booster shots have limited effect on Omicron

Swedish HCW study shows COVID booster shots have limited effect on Omicron

5 Apr 2022
SARS-CoV-2 ORF8 interferes with antibody-dependent cellular cytotoxicity

SARS-CoV-2 ORF8 interferes with antibody-dependent cellular cytotoxicity

5 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback